XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders' Equity and Share-based Compensation (Tables)
3 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Restricted Stock Units Activity
Time-based Restricted Stock Units (TRSU)
The following table summarizes the Company's TRSU activities for the three months ended September 30, 2023:
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual
Term (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 20231,385,065 $32.48 1.73$45,430,132 
Granted76,800 $32.79 
Vested(44,655)$31.18 
Forfeited(14,501)$33.55 
Nonvested at September 30, 20231,402,709 $32.53 1.57$41,856,837 
The following table summarizes the Company’s PRSUs activities for the three months ended September 30, 2023:

 Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual Term
(Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2023526,714 $32.19 1.78$17,276,219 
Granted— $— 
Vested— $— 
Forfeited— $— 
Nonvested at September 30, 2023526,714 $32.19 1.52$15,717,146 
Summary of Stock Option Activities The following table summarizes the Company's stock option activities for the three months ended September 30, 2023:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2023319,375 $7.53 0.72$8,071,631 
Exercised(60,000)$7.44 $1,342,961 
Outstanding at September 30, 2023259,375 $7.55 0.47$5,782,281 
Options vested and expected to vest259,375 $7.55 0.47$5,782,281 
Exercisable at September 30, 2023259,375 $7.55 0.47$5,782,281 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows:
Three Months Ended September 30,
2023
Volatility rate64.0%
Risk-free interest rate4.6%
Expected term1.3 years
Dividend yield0%
Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Expense
The total share-based compensation expense recognized in the Condensed Consolidated Statements of Income for the periods presented was as follows:
Three Months Ended September 30,
20232022
(in thousands)
Cost of goods sold$212 $1,788 
Research and development2,494 
Selling, general and administrative700 6,314 
$918 $10,596